| Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
| Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More | Alex Lash | 03/22/19 | National |
| Blackstone, Novartis Start Up Anthos With $250M and a Heart Drug | Ben Fidler | 02/27/19 | Boston |
| InCarda Breathes In $42M for Clinical Tests of Inhalable Heart Drug | Frank Vinluan | 11/08/18 | San Francisco |
| Boston Scientific Continues M&A Streak with $202M Deal for Cryterion | Frank Vinluan | 07/05/18 | Boston |
| Driverless Cars, UW Spinouts, & CRISPR: This Week’s WI Watchlist | Jeff Buchanan | 01/30/17 | Wisconsin |
| HealthDecision Founder Hangs Up the White Coat to Focus on Startup | Jeff Buchanan | 05/18/16 | Wisconsin |
| Acutus Medical Raises $75M to Map Abnormal Currents of the Heart | Bruce V. Bigelow | 03/22/16 | San Diego |
| Heart Drug Safety Concerns Prompt Shutdown at Laguna Pharmaceuticals | Bruce V. Bigelow | 12/06/15 | San Diego |
| West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More | Alex Lash | 10/30/14 | Seattle |
| So Far, Little Proof That Digital Health Is Healthy. Does It Matter? | Alex Lash | 10/07/14 | National |
| San Diego Life Sciences Roundup: Isis, Elcelyx, Acutus, and More | Bruce V. Bigelow | 06/27/13 | San Diego |
| Ailing ARCA Biopharma Seeks $20M to Fund Trials, Stay in Business | Michael Davidson | 05/30/13 | Boulder/Denver |
| East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More | Catherine Arnst | 01/04/13 | Boston |
| East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer | Catherine Arnst | 11/23/12 | Boston |
| The Stroke Prevention War is On: FDA Approves J&J/Bayer Contender | Arlene Weintraub | 11/07/11 | New York |
| UW Spinoff Cardiac Insight Looks to Spot Common Cause of Stroke with Stick-On Device | Luke Timmerman | 11/02/11 | Seattle |
| Latest in Stroke-Prevention Saga: FDA Panel Backs Drug From J&J and Bayer | Arlene Weintraub | 09/09/11 | New York |
| Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer | Arlene Weintraub | 09/08/11 | New York |
| Bristol and Pfizer Get Boost from Apixaban Data | Arlene Weintraub | 06/23/11 | New York |
| $6.6M for Cardiorobotics | Ryan McBride | 03/01/11 | Boston |
| CardioFocus Finds $30.6M for Atrial Fibrillation Treatment | Ryan McBride | 02/25/11 | Boston |
| Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News | Erin Kutz | 01/21/11 | Boston |
| Boston Scientific Acquires Atritech | Ryan McBride | 01/19/11 | Boston |
| Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat | Luke Timmerman | 10/28/09 | San Diego |
| Cardiorobotics, Developer of Snake Robot Technology, Aims to Alter Cardiac Surgery | Eric Hal Schwartz | 08/06/09 | Boston |
| Medtronic To Pick Up Ablation Frontiers for $225 Million Upfront | Bruce V. Bigelow | 01/12/09 | San Diego |
